University of California San Francisco

Carlos U. Corvera, M.D., FACS
Carlos
Covera
MD, FACS

Professor of Surgery 
Division of Surgical Oncology 
Chief, Section of HPB-GISS (HepatoPancreatoBiliary, GI, Skin, Sarcoma Surgery) 
Maurice Galante Distinguished Professorship in Hepatobiliary Surgery

Address

533 Parnassus Avenue, #549C
San Francisco, CA 94117
United States

Email: [email protected]
Phone: 415-221-4810 ext. 4019

ORCID: 0000-0002-3092-8657

Biography

Dr. Carlos Corvera is chief of the Hepatobiliary & Pancreatic Surgery Program at UCSF Medical Center and a cancer surgeon at the UCSF Helen Diller Family Comprehensive Cancer Center. His expertise includes the diagnosis and treatment of malignant as well as benign diseases of the liver, bile ducts, gallbladder and pancreas. He specializes in complex conventional surgical procedures yet has also developed innovations in laparoscopic (minimally invasive) surgical techniques for the liver and pancreas.

In his research, Corvera focuses on the mechanisms that underlie inflammation, thickening and scarring in the biliary tract.

Corvera graduated from the University of California, San Diego School of Medicine. He completed a residency in general surgery at UCSF. At Memorial Sloan Kettering Cancer Center in New York City, he completed a clinical fellowship in surgical oncology as well as a fellowship in hepatobiliary surgery.

Videos

Education

Institution Degree Dept or School End Date
Memorial Sloan Kettering Cancer Center, New York Hepatobiliary Surgery Surgery 2002
Memorial Sloan Kettering Cancer Center , New York Surgical Oncology Clinical Fellowship Surgery 2001
University of California, San Francisco General Surgery Residency School of Medicine 2000
University of California San Diego M.D. School of Medicine 1993

Board Certifications

  • American Board of Surgery

Clinical Expertise

Ascites
Bile Duct Injuries
Bile Duct Strictures
Bile Duct Cancer (Cholangiocarcinoma)
Gastrointestinal Carcinoid Tumor
Gastrointestinal Stromal Tumor (GIST)
Choledochal Cysts
Portal Hypertension
Liver Cancer (Hepatocellular Carcinoma)
Minimally Invasive Liver & Pancreas Surgery
Melanoma
Pancreatic Cancer
Pancreatic Cysts
Soft Tissue Sarcomas
Liver Cysts
Liver Metastases
Gallbladder Cancer
Stomach (Gastric) Cancer
Pancreatic Neuroendocrine (Islet Cell) Tumors
Bridging Therapies to Downstage HCC in Setting of Liver Transplantation

Program Affiliations

Hepatobiliary and Pancreas Surgery Program
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Department of Surgery at the San Francisco VA

Research Narrative

Dr. Corvera's scientific research interest is focused on understanding the mechanisms of biliary tract fibrosis and inflammation.  More specifically, he is interested in studying the clinical consequences of biliary fibrosis-- mainly cholestatisis. Cholestasis is characterized by impaired bile flow causing a high concentration of bile acids in the liver and the circulation.  Prolonged exposure to bile acids in the liver can progress to end-stage liver disease and cirrhosis. In the gastrointestinal tract, the absence of bile flow causes profound local and systemic metabolic disturbances. Dr.Corvera is actively investigating the role of a novel cell surface receptor specific for bile acids that may play a critical role in normal and disease states.

Research Interests

Proteases and Proteinase Activated Receptors in the Biliary Tract

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 101
  1. Impact of pre-operative positron emission tomography in gallbladder cancer.
    Leung U, Pandit-Taskar N, Corvera CU, D'Angelica MI, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, Fong Y| | PubMed
  2. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
    Ho EY, Cozen ML, Shen H, Lerrigo R, Trimble E, Ryan JC, Corvera CU, Monto A, HOVAS Group (Hepatocellular Carcinoma Treatment Outcome at VA San Francisco)| | PubMed
  3. The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts.
    Jensen DD, Godfrey CB, Niklas C, Canals M, Kocan M, Poole DP, Murphy JE, Alemi F, Cottrell GS, Korbmacher C, Lambert NA, Bunnett NW, Corvera CU| | PubMed
  4. The TGR5 receptor mediates bile acid-induced itch and analgesia.
    Alemi F, Kwon E, Poole DP, Lieu T, Lyo V, Cattaruzza F, Cevikbas F, Steinhoff M, Nassini R, Materazzi S, Guerrero-Alba R, Valdez-Morales E, Cottrell GS, Schoonjans K, Geppetti P, Vanner SJ, Bunnett NW, Corvera CU| | PubMed
  5. Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.
    Rajagopal S, Kumar DP, Mahavadi S, Bhattacharya S, Zhou R, Corvera CU, Bunnett NW, Grider JR, Murthy KS| | PubMed
  6. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.
    Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW, Corvera CU| | PubMed
  7. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract.
    Cottrell GS, Alemi F, Kirkland JG, Grady EF, Corvera CU, Bhargava A| | PubMed
  8. Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity.
    Warne JP, Alemi F, Reed AS, Varonin JM, Chan H, Piper ML, Mullin ME, Myers MG, Corvera CU, Xu AW| | PubMed
  9. Visual vignette. What is the diagnosis? Insulin-secreting tumor.
    Thompson M, Hiniker A, Duh QY, Corvera CU| | PubMed
  10. Laparoscopic treatment of liver tumours using a two-needle probe bipolar radiofrequency ablation device.
    Alemi F, Kwon E, Chiu J, Aoki H, Stewart L, Corvera CU| | PubMed
101
View all 101 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 101
  1. Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer.
    Ejie J, Ashraf Ganjouei A, Hernandez S, Wang JJ, Romero-Hernandez F, Foroutani L, Hirose K, Nakakura E, Corvera CU, Alseidi A, Adam MA| | PubMed
  2. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed
  3. ASO Author Reflections: Innovative Robot-Assisted Endoluminal Resection for Gastroesophageal Junction Leiomyomas.
    Foroutani L, Ashraf Ganjouei A, Wang JJ, Aburayya BI, Corvera C, Alseidi A, Adam MA| | PubMed
  4. Robotic-Assisted Endoluminal Resection of Gastroesophageal Junction Leiomyoma with Transoral Specimen Extraction: Technique, Outcome, and Safety.
    Foroutani L, Ashraf Ganjouei A, Wang J, Aburayya BI, Corvera C, Alseidi A, Adam MA| | PubMed
  5. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).
    Yin H, Romero-Hernandez F, Ganjouei AA, Wang JJ, Brown A, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Wilhelm A, Peng JS, Alseidi A, Adam MA| | PubMed
  6. Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases.
    Moaven O, Mainali BB, Valenzuela CD, Russell G, Cheung T, Corvera CU, Wisneski AD, Cha CH, Stauffer JA, Shen P| | PubMed
  7. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients.
    Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK| | PubMed
  8. Resection versus resection with ablation: Analysis from the colorectal liver operative metastasis international collaborative.
    Mainali BB, Valenzuela CD, Moaven O, Stauffer JA, Del Piccolo NR, Cheung T, Corvera CU, Wisneski AD, Cha CH, Zarandi NP, Dourado J, Russell G, Shen P| | PubMed
  9. ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK| | PubMed
  10. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed
  11. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
    Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE| | PubMed
  12. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK| | PubMed
  13. Long-Term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.
    Yogo A, Paciorek A, Kasai Y, Moon F, Hirose K, Corvera CU, Bergsland EK, Nakakura EK| | PubMed
  14. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis.
    Casey M, Brown A, Romero-Hernandez F, Wang JJ, Ganjouei AA, Tozzi F, Rashidian N, Kirkwood K, Corvera C, Nakakura E, Alseidi A, Adam M| | PubMed
  15. Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome.
    Berardi G, Cucchetti A, Sposito C, Ratti F, Nebbia M, D'Souza DM, Pascual F, Dogeas E, Tohme S, Vitale A, D'Amico FE, Alessandris R, Panetta V, Simonelli I, Colasanti M, Russolillo N, Moro A, Fiorentini G, Serenari M, Rotellar F, Zimitti G, Famularo S, Ivanics T, Donando FG, Hoffman D, Onkendi E, Essaji Y, Giuliani T, Lopez Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Sapisochin G, Torzilli G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon DCH, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Aldrighetti L, Kingham TP, Mazzaferro V| | PubMed
  16. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
    Wong P, Wisneski AD, Tsai KK, Chang TT, Hirose K, Nakakura EK, Daud AI, Maker AV, Corvera CU| | PubMed
  17. Portal Vein Thrombosis After Transarterial Embolization for Hepatocellular Carcinoma.
    Schwab ME, Decker HC, Monto A, Sawhney R, Corvera CU| | PubMed
  18. Intraoperative hepatic artery infusion pump perfusion testing with indocyanine green near-infrared imaging offers multiple potential advantages.
    Wong P, Hoffman D, Pollini T, Zampese M, Corvera CU, Maker AV| | PubMed
  19. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
    Pollini T, Tran T, Wong P, Adam MA, Alseidi A, Corvera C, Hirose K, Nakakura E, Warren R, Maker VK, Maker AV| | PubMed
  20. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  21. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  22. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  23. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
    Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E| | PubMed
  24. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
    Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, Ilson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, Mukherjee S, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LA| | PubMed
  25. Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome.
    Berardi G, Ivanics T, Sapisochin G, Ratti F, Sposito C, Nebbia M, D'Souza DM, Pascual F, Tohme S, D'Amico FE, Alessandris R, Panetta V, Simonelli I, Del Basso C, Russolillo N, Fiorentini G, Serenari M, Rotellar F, Zimitti G, Famularo S, Hoffman D, Onkendi E, Lopez-Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Torzilli G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon CHD, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Mazzaferro V, Aldrighetti L, Kingham TP| | PubMed
  26. Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Valenzuela CD, Moaven O, Solsky IB, Stauffer JA, Del Piccolo NR, Cheung T, Corvera CU, Wisneski AD, Cha CH, Pourhabibi Zarandi N, Dourado J, Perry KC, Russell G, Shen P| | PubMed
  27. Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
    Solsky I, Moaven O, Valenzuela CD, Lundy M, Stauffer JA, Del Piccolo NR, Cheung T, Corvera CU, Wisneski AD, Cha C, Zarandi NP, Dourado J, Russell G, Levine EA, Votanopoulos KI, Shen P| | PubMed
  28. Machine Learning Models for Predicting the Outcomes of Surgical Treatment of Colorectal Liver Metastases.
    Moaven O, Tavolara TE, Valenzuela CD, Cheung TT, Corvera CU, Cha CH, Stauffer JA, Niazi MKK, Gurcan MN, Shen P| | PubMed
  29. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA| | PubMed
  30. Model to predict major complications following liver resection for HCC in patients with metabolic syndrome.
    Berardi G, Ratti F, Sposito C, Nebbia M, D'Souza DM, Pascual F, Dogeas E, Tohme S, D'Amico FE, Alessandris R, Simonelli I, Del Basso C, Russolillo N, Moro A, Fiorentini G, Serenari M, Rotellar F, Zimmitti G, Famularo S, Ivanics T, Hoffman D, Onkendi E, Essaji Y, Lopez Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Torzilli G, Sapisochin G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon CHD, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Mazzaferro V, Aldrighetti L, Kingham TP| | PubMed
  31. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
    Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA| | PubMed
  32. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  33. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery.
    Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  34. Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC).
    Valenzuela CD, Moaven O, Gawdi R, Stauffer JA, Del Piccolo NR, Cheung TT, Corvera CU, Wisneski AD, Cha C, Pourhabibi Zarandi N, Dourado J, Perry KC, Russell G, Shen P| | PubMed
  35. Primary Cutaneous Malignant Perivascular Epithelioid Cell Tumor Mimicking Undifferentiated Pleomorphic Sarcoma: A Report of a Rare Entity.
    Neumann NM, Cornelia Ding CK, Borgen A, Corvera CU, North JP, Qorbani A, Horvai AE| | PubMed
  36. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    Gawdi R, Valenzuela CD, Moaven O, Stauffer JA, Del Piccolo NR, Cheung T, Corvera CU, Wisneski AD, Cha C, Russell G, Zarandi N, Dourado J, Shen P| | PubMed
  37. Association of primary tumor laterality with surgical outcomes for colorectal liver metastases: results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Valenzuela CD, Moaven O, Gawdi R, Stauffer JA, Del Piccolo NR, Cheung TT, Corvera CU, Wisneski AD, Cha C, Mangieri CW, Zarandi NP, Dourado J, Perry KC, Russell G, Shen P| | PubMed
  38. ASO Visual Abstract: Determining Hospital Volume Threshold for the Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  39. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  40. Multifocal pancreatic PPoma in the setting of MEN1: Case report and review of literature.
    Mosenia A, Ward C, Yee A, Qorbani A, Corvera C| | PubMed
  41. Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis.
    Thiruvengadam NR, Miranda J, Kim C, Behr S, Corvera C, Dai SC, Kirkwood K, Harris HW, Hirose K, Nakakura E, Ostroff JW, Kochman ML, Arain MA| | PubMed
  42. Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.
    Mahuron KM, Kasai Y, Javeed ZA, Bergsland EK, Hirose K, Corvera CU, Nakakura EK| | PubMed
  43. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center.
    Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU| | PubMed
  44. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
    Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU| | PubMed
  45. A rare presentation of hepatolithiasis in an adolescent patient: A case report.
    Freise J, Mena J, Wen KW, Stoller M, Ho S, Corvera C| | PubMed
  46. Ampullary stenosis and choledocholithiasis post Roux-En-Y gastric bypass: challenges of biliary access and intervention.
    Wisneski AD, Carter J, Nakakura EK, Posselt A, Rogers SJ, Cello JP, Arain M, Kirkwood KS, Hirose K, Stewart L, Corvera CU| | PubMed
  47. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  48. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
    Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  49. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  50. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
    Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA| | PubMed
  51. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization?
    Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE| | PubMed
  52. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma.
    Lee JY, Huo EJ, Weinstein S, Santos C, Monto A, Corvera CU, Yee J, Hope TA| | PubMed
  53. Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography.
    Hope TA, Aslam R, Weinstein S, Yeh BM, Corvera CU, Monto A, Yee J| | PubMed
  54. Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement.
    Ikram NS, Yee J, Weinstein S, Yeh BM, Corvera CU, Monto A, Hope TA| | PubMed
  55. Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience.
    Mari Aparici C, Behr SC, Seo Y, Kelley RK, Corvera C, Gao KT, Aggarwal R, Evans MJ| | PubMed
  56. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
    Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH| | PubMed
  57. In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis.
    Rezvani M, Español-Suñer R, Malato Y, Dumont L, Grimm AA, Kienle E, Bindman JG, Wiedtke E, Hsu BY, Naqvi SJ, Schwabe RF, Corvera CU, Grimm D, Willenbring H| | PubMed
  58. Management of Postoperative Hepatic Failure.
    Qadan M, Garden OJ, Corvera CU, Visser BC| | PubMed
  59. Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging.
    Hope TA, Verdin EF, Bergsland EK, Ohliger MA, Corvera CU, Nakakura EK| | PubMed
  60. The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.
    Lieu T, Jayaweera G, Zhao P, Poole DP, Jensen D, Grace M, McIntyre P, Bron R, Wilson YM, Krappitz M, Haerteis S, Korbmacher C, Steinhoff MS, Nassini R, Materazzi S, Geppetti P, Corvera CU, Bunnett NW| | PubMed
  61. Impact of pre-operative positron emission tomography in gallbladder cancer.
    Leung U, Pandit-Taskar N, Corvera CU, D'Angelica MI, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, Fong Y| | PubMed
  62. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
    Ho EY, Cozen ML, Shen H, Lerrigo R, Trimble E, Ryan JC, Corvera CU, Monto A, HOVAS Group (Hepatocellular Carcinoma Treatment Outcome at VA San Francisco)| | PubMed
  63. The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts.
    Jensen DD, Godfrey CB, Niklas C, Canals M, Kocan M, Poole DP, Murphy JE, Alemi F, Cottrell GS, Korbmacher C, Lambert NA, Bunnett NW, Corvera CU| | PubMed
  64. The TGR5 receptor mediates bile acid-induced itch and analgesia.
    Alemi F, Kwon E, Poole DP, Lieu T, Lyo V, Cattaruzza F, Cevikbas F, Steinhoff M, Nassini R, Materazzi S, Guerrero-Alba R, Valdez-Morales E, Cottrell GS, Schoonjans K, Geppetti P, Vanner SJ, Bunnett NW, Corvera CU| | PubMed
  65. Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.
    Rajagopal S, Kumar DP, Mahavadi S, Bhattacharya S, Zhou R, Corvera CU, Bunnett NW, Grider JR, Murthy KS| | PubMed
  66. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.
    Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW, Corvera CU| | PubMed
  67. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract.
    Cottrell GS, Alemi F, Kirkland JG, Grady EF, Corvera CU, Bhargava A| | PubMed
  68. Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity.
    Warne JP, Alemi F, Reed AS, Varonin JM, Chan H, Piper ML, Mullin ME, Myers MG, Corvera CU, Xu AW| | PubMed
  69. Visual vignette. What is the diagnosis? Insulin-secreting tumor.
    Thompson M, Hiniker A, Duh QY, Corvera CU| | PubMed
  70. Laparoscopic treatment of liver tumours using a two-needle probe bipolar radiofrequency ablation device.
    Alemi F, Kwon E, Chiu J, Aoki H, Stewart L, Corvera CU| | PubMed
  71. Hepatic surgery at a VA tertiary medical center: lessons learned.
    Alemi F, Kwon E, Freise C, Kang SM, Hirose R, Stewart L, Corvera CU| | PubMed
  72. Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center.
    Russell JS, Sawhney R, Monto A, Nanavati S, Davoren JB, Aslam R, Corvera CU| | PubMed
  73. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.
    Lavoie B, Balemba OB, Godfrey C, Watson CA, Vassileva G, Corvera CU, Nelson MT, Mawe GM| | PubMed
  74. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system.
    Poole DP, Godfrey C, Cattaruzza F, Cottrell GS, Kirkland JG, Pelayo JC, Bunnett NW, Corvera CU| | PubMed
  75. Hemorrhagic cholecystitis.
    Parekh J, Corvera CU| | PubMed
  76. Giant mesenteric cystic lymphangioma presenting with abdominal pain and masquerading as a gynecologic malignancy.
    Maa J, Wa C, Jaigirdir A, Cho SJ, Corvera CU| | PubMed
  77. Reversible surgical model of biliary inflammation and obstructive jaundice in mice.
    Kirkland JG, Godfrey CB, Garrett R, Kakar S, Yeh BM, Corvera CU| | PubMed
  78. Abdominal actinomycosis after laparoscopic cholecystectomy: a rare complication of bile spillage.
    Ozgediz D, Zheng J, Smith EB, Corvera CU| | PubMed
  79. Perforated ulcer mimicking a spontaneous pneumothorax in a patient with congenital diaphragmatic hernia.
    Maa J, Lubbock C, Harrison M, Corvera C| | PubMed
  80. Caudate split for open and laparoscopic liver resections.
    Chang TT, Corvera CU| | PubMed
  81. Basal cell carcinoma does metastasize.
    Ozgediz D, Smith EB, Zheng J, Otero J, Tabatabai ZL, Corvera CU| | PubMed
  82. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival.
    Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Stewart L, Corvera CU| | PubMed
  83. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
    Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D'Angelica M, Fong Y, Jarnagin WR| | PubMed
  84. Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder.
    Kirkland JG, Cottrell GS, Bunnett NW, Corvera CU| | PubMed
  85. Role of calcitonin receptor-like receptor in colonic motility and inflammation.
    Clifton MS, Hoy JJ, Chang J, Idumalla PS, Fakhruddin H, Grady EF, Dada S, Corvera CU, Bhargava A| | PubMed
  86. Bipolar pulse coagulation for resection of the cirrhotic liver.
    Corvera CU, Dada SA, Kirkland JG, Garrett RD, Way LW, Stewart L| | PubMed
  87. Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature.
    Corvera CU, Dunnican WJ, Blumgart LH, D'Angelica M| | PubMed
  88. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma.
    Corvera CU, Blumgart LH, Darvishian F, Klimstra DS, DeMatteo R, Fong Y, D'Angelica M, Jarnagin WR| | PubMed
  89. The missing thyroid.
    Sturgeon C, Corvera C, Clark OH| | PubMed
  90. Retrocardiac parathyroid tumor: a rare mediastinal site.
    Corvera CU, Jablons D, Morita E, Clark OH| | PubMed
  91. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.
    Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH| | PubMed
  92. Role of laparoscopy in the evaluation of biliary tract cancer.
    Corvera CU, Weber SM, Jarnagin WR| | PubMed
  93. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase.
    Steinhoff M, Corvera CU, Thoma MS, Kong W, McAlpine BE, Caughey GH, Ansel JC, Bunnett NW| | PubMed
  94. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2.
    Corvera CU, Déry O, McConalogue K, Gamp P, Thoma M, Al-Ani B, Caughey GH, Hollenberg MD, Bunnett NW| | PubMed
  95. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma.
    Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ| | PubMed
  96. Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2.
    McConalogue K, Corvera CU, Gamp PD, Grady EF, Bunnett NW| | PubMed
  97. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.
    Déry O, Corvera CU, Steinhoff M, Bunnett NW| | PubMed
  98. A hospital's annual rate of esophagectomy influences the operative mortality rate.
    Patti MG, Corvera CU, Glasgow RE, Way LW| | PubMed
  99. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
    Corvera CU, Déry O, McConalogue K, Böhm SK, Khitin LM, Caughey GH, Payan DG, Bunnett NW| | PubMed
  100. Recent advances. General surgery.
    Corvera CU, Kirkwood KS| | PubMed
  101. Heterogeneity of P2u- and P2y-purinergic receptor regulation of phospholipases in MDCK cells.
    Firestein BL, Xing M, Hughes RJ, Corvera CU, Insel PA| | PubMed